trending Market Intelligence /marketintelligence/en/news-insights/trending/ef0ovhckxx423vup52aqgw2 content esgSubNav
In This List

Novelion Therapeutics names executive chair, interim CEO

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes

Blog

Investment Banking Essentials Newsletter April Edition - 2022


Novelion Therapeutics names executive chair, interim CEO

Canada's Novelion Therapeutics Inc. appointed Mark Corrigan to serve as executive chair of the board.

Further, COO Jeff Hackman was named interim CEO.

The company said in relation to Corrigan's appointment, the office of the CEO — comprising Corrigan, Hackman and former Chair Jason Aryeh — will be disbanded.

Novelion develops therapies for individuals with rare diseases.